Skip to Main Content

Category Archives: HIV

05.08.20

Lessons from the HIV Policy Lab: tracking national HIV policies and ART access amidst COVID-19

By Mara Pillinger

This post was authored by Kate Daley (with Mara Pillinger)   COVID-19 presents a unique opportunity to accelerate and expand national policies on differentiated service delivery (DSD) for people living with HIV (PLHIV). DSD is “a responsive, client-centred approach that simplifies and adapts HIV services across the cascade to better serve individual needs and reduce […]

Categories:

04.30.20

O’Neill Institute Releases Publication on Meeting the Needs of People Living with HIV

By Sean Bland

This week, the O’Neill Institute released a new publication, Big Ideas: Better Meeting the Needs of People Living with HIV Is How to End the HIV Epidemic. This report highlights actions that can be taken by jurisdictions and advocates to improve the health of all people living with HIV. It was written by me and Jeffrey […]

Categories:
Tags:
Thematic Areas: Infectious Diseases

03.26.20

O’Neill Institute Releases Publication on the USPSTF PrEP Recommendation

By Sean Bland

Today, the O’Neill Institute released a new publication, Quick Take: The USPSTF PrEP Recommendation. The Quick Take discusses the final recommendation for pre-exposure prophylaxis (PrEP) from the United States Preventive Services Task Force (USPSTF) and why the PrEP recommendation matters. It was written by me and Jeffrey S. Crowley, Program Director of the O’Neill Institute’s Infectious Disease […]

Tags:
Thematic Areas: Infectious Diseases

01.31.20

Policy Work Is Needed to Eliminate Barriers to Syringe Services Programs

By Sean Bland

Injection drug use has been linked to outbreaks of HIV in several jurisdictions across the United States. In 2014-2015, Scott County, Indiana, experienced an outbreak that involved 181 people being diagnosed with HIV as a result of injection drug use. This HIV outbreak in a rural community that typically saw about 5 HIV diagnoses per […]

Tags:
Thematic Areas: Infectious Diseases

12.19.19

Byanyima’s Strategy: Focus on Injustice & Innovation in the Fight Against HIV

By Mara Pillinger

Last week, UNAIDS new Executive Director, Dr. Winnie Byanyima, announced the creation of a strategic advisory group to be co-chaired by Georgetown’s own Matt Kavanagh (along with Quarraisha Abdool Karim, Associate Scientific Director at CAPRISA, and Rico Gustav, Executive Director GNP+). Since you’re reading a policy research institute’s blog, you probably don’t need convincing that […]

Tags:

11.21.19

Using HIV Prevention and Care Systems to Address the Rise in Sexually Transmitted Infections

By Sean Bland

This week, the O’Neill Institute released a new brief, Big Ideas: HIV Prevention and Care Systems Have Critical Roles in Addressing Sexually Transmitted Infections. This brief discusses key actions for HIV programs to reduce the public health impact of sexually transmitted infections (STIs) in the United States. It was written by me and Jeffrey S. […]

Thematic Areas: Infectious Diseases

11.14.19

The Challenges of Turning Policies Into Data

By Mara Pillinger

If you’re reading this blog, you’re probably more than familiar with evidence-based policymaking. You may not be as used to thinking about laws and policies themselves as a form of data. But they can be. By collecting, mapping and analyzing laws/policies across jurisdictions and over time, we can systematically evaluate the relationships between policies and […]

Tags:

11.08.19

Overdose Prevention Sites Are an Effective Approach to Address Infectious Diseases Associated with Injection Drug Use

By Sean Bland

The United States has been battling a serious drug use epidemic for several years. While opioids including prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl have received significant attention, other drug use, including use of stimulants like cocaine and methamphetamine, remain major public health issues as well. Drug overdose deaths continue to increase, and […]

Tags:
Thematic Areas: Infectious Diseases

10.18.19

More or the same? Reflecting on debates around the Global Fund’s mandate

By Mara Pillinger

Last week, the Global Fund met its replenishment target of $14B. The news was greeted mostly with sighs of relief, especially because it was a near thing. The Global Fund is the largest star in the global health firmament, channeling more money than any other multilateral actor.* It has leveraged this funding to impressive ends. […]

Tags:

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.